Free Trial

Segall Bryant & Hamill LLC Invests $12.88 Million in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background
Remove Ads

Segall Bryant & Hamill LLC bought a new position in shares of Chemed Co. (NYSE:CHE - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 24,311 shares of the company's stock, valued at approximately $12,880,000. Segall Bryant & Hamill LLC owned 0.16% of Chemed at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. UMB Bank n.a. boosted its holdings in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after buying an additional 39 shares during the last quarter. Atala Financial Inc purchased a new position in shares of Chemed in the fourth quarter valued at approximately $29,000. CBIZ Investment Advisory Services LLC boosted its stake in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after acquiring an additional 22 shares during the last quarter. Trust Co. of Vermont purchased a new stake in shares of Chemed during the fourth quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC raised its stake in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after purchasing an additional 34 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Price Performance

Chemed stock traded down $6.42 during trading on Friday, reaching $605.94. 162,388 shares of the company were exchanged, compared to its average volume of 93,565. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $642.68. The stock's 50 day simple moving average is $574.16 and its two-hundred day simple moving average is $566.66. The company has a market capitalization of $8.87 billion, a P/E ratio of 30.62, a PEG ratio of 2.15 and a beta of 0.43.

Remove Ads

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is currently 10.05%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on CHE shares. Royal Bank of Canada lifted their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Check Out Our Latest Stock Report on Chemed

Insiders Place Their Bets

In other Chemed news, VP Brian C. Judkins acquired 145 shares of the firm's stock in a transaction that occurred on Monday, December 30th. The shares were purchased at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the acquisition, the vice president now owns 1,678 shares of the company's stock, valued at approximately $871,721. The trade was a 9.46 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares of the company's stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by insiders.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 Quantum Computing Stocks to Watch in 2025 (That Aren't Rigetti)

3 Quantum Computing Stocks to Watch in 2025 (That Aren't Rigetti)

Investors are buying the dip on quantum computing stocks, but is now the right time to get in? MarketBeat analyst Chris Markoch breaks down three intriguing picks beyond Rigetti.

Related Videos

Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads